{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:41:43Z","timestamp":1756384903826},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00106-004-1116-y","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T12:51:02Z","timestamp":1091019062000},"page":"462-466","source":"Crossref","is-referenced-by-count":2,"title":["Akute Atemwegsverlegung durch erworbene H\u00e4mophilie\u00a0A"],"prefix":"10.1007","volume":"53","author":[{"given":"J. B.","family":"Weise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Plendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gieseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Preu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Maune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1116_CR1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1288\/00005537-199407000-00002","volume":"104","author":"Bogdan","year":"1994","unstructured":"Bogdan CJ, Strauss M, Ratnoff OD (1994) Airway obstruction in hemophilia (factor VIII deficiency): a 28-year institutional review. Laryngoscope 104: 789\u2013794","journal-title":"Laryngoscope"},{"key":"1116_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0049-3848(91)90271-W","volume":"63","author":"Carmona","year":"1991","unstructured":"Carmona E, Aznar JA, Jorquera JI, Villanueva MJ, Sanchez-Cuenca JM (1991) Detection of two different anti-factor VIII\/von Willebrand factor anti-bodies of the IgA class in a hemophilic patient with a polyclonal factor VIII inhibitor of the IgG class. Thromb Res 63: 73\u201384","journal-title":"Thromb Res"},{"key":"1116_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2141.2003.04731.x","volume":"124","author":"Collins","year":"2004","unstructured":"Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R (2004) A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 124 (1): 86\u201390","journal-title":"Br J Haematol"},{"key":"1116_CR4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1055\/s-0038-1665434","volume":"78","author":"Hay","year":"1997","unstructured":"Hay CR, Negrier C, Ludlam CA (1997) The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 78: 1463\u20131467","journal-title":"Thromb Haemost"},{"key":"1116_CR5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1365-2141.2002.03835_5.x","volume":"119","author":"Kain","year":"2002","unstructured":"Kain S, Copeland TS, Leahy MF (2002) Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab). Br J Haematol 119 (2): 578","journal-title":"Br J Haematol"},{"key":"1116_CR6","unstructured":"Koscielny J, Kiesewetter H (2003) Erworbene Hemmk\u00f6rper-H\u00e4mophilie bei malignen Tumoren. In: IFAHS (Hrsg) Onkologische Pharmazie. Onkopress, Oldenburg, S\u00a01\u20134"},{"key":"1116_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0049-3848(01)00385-1","volume":"104","author":"Matsumoto","year":"2001","unstructured":"Matsumoto T, Shima M, Fukuda K et al. (2001) Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease. Thromb Res 104: 381\u2013388","journal-title":"Thromb Res"},{"key":"1116_CR8","first-page":"172","volume":"15","author":"Moccia","year":"2000","unstructured":"Moccia F, Tognoni E, Boccaccio P (2000) Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy. Ann Ital Med Int 15 (2): 172\u2013176","journal-title":"Ann Ital Med Int"},{"key":"1116_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2516.2001.00521.x","volume":"7","author":"Rizza","year":"2001","unstructured":"Rizza C, Spooner R, Giagrande P (2001) Treatment of haemophilia in the United Kingdom 1981\u201396. Haemophilia 7: 349\u2013359","journal-title":"Haemophilia"},{"key":"1116_CR10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0038-1650581","volume":"76","author":"Schulman","year":"1996","unstructured":"Schulman S, Langevitz P, Livneh A, Mortinowitz U, Seligsohn U, Varon D (1996) Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thromb Haemost 76: 344\u2013346","journal-title":"Thromb Haemost"},{"key":"1116_CR11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s002770000246","volume":"80","author":"Shwaiki","year":"2001","unstructured":"Shwaiki A, Lara L, Ahmed F, Crock R, Rutecki GW, Whittier FC (2001) Acquired inhibitor to factor VIII in small cell lung cancer: a case report and review of the literature. Ann Hematol 80 (2): 124\u2013126","journal-title":"Ann Hematol"},{"key":"1116_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1653759","volume":"73","author":"Verbruggen","year":"1995","unstructured":"Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E (1995) The Nijmegen modification of the Bethesda assay for factor VIII.C inhibitors: improved specifity and reliability. Thromb Haemost 73: 247\u2013251","journal-title":"Thromb Haemost"},{"key":"1116_CR13","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2002-03-0765","volume":"100","author":"Wiestner","year":"2002","unstructured":"Wiestner A, Cho HJ, Asch AS et al. (2002) Rituximab in the treatment of acquired factor VIII inhibitors. Blood 100 (9): 3426\u20133428","journal-title":"Blood"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-004-1116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-004-1116-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-004-1116-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T21:35:39Z","timestamp":1585863339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-004-1116-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s00106-004-1116-y","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}